Century Therapeutics, Inc. (IPSC) Institutional Ownership

Ownership Summary

Century Therapeutics, Inc. (NASDAQ:IPSC) appears in 45 institutional 13F filings for the quarter ending December 2025.

• These investors collectively held 29.6% of Century Therapeutics's outstanding shares in December 2025, up from 23.4% in September 2025.
• They increased total shares held in Century Therapeutics by 67.61% from last quarter, and the number of investors in IPSC decreased 37.5% annually.
• Of these 45 holders, 17 added to their stakes in Century Therapeutics, 12 trimmed positions, and 16 made no changes.
• Altogether, these fund groups held 25.63Mn shares in IPSC by December 2025, up by 10.34Mn shares quarter on quarter, and down 11.37Mn shares year over year.
• Point72 Asset Management, L.P. holds the largest position in IPSC at 5.96Mn shares as of December 31, 2025, or 6.89% of shares outstanding.
• The largest buyers of Century Therapeutics for the quarter ending December 2025 were Point72 Asset Management, L.P. (5.96Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.84Mn), Spruce Street Capital LP (1.42Mn), DAFNA Capital Management LLC (1.09Mn), TWO SIGMA INVESTMENTS, LP (584.47K).
• Leading sellers of Century Therapeutics shares for the quarter ending December 2025 were RENAISSANCE TECHNOLOGIES LLC (1.24Mn), GSA CAPITAL PARTNERS LLP (270.28K), MILLENNIUM MANAGEMENT LLC (133.39K), FMR LLC (120.6K), Barclays Plc (61.95K).
• Century Therapeutics's 10 largest shareholders as of December 2025 include Point72 Asset Management, L.P. (5.96Mn), DAFNA Capital Management LLC (2.79Mn), VANGUARD GROUP INC (2.1Mn), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.84Mn), TWO SIGMA INVESTMENTS, LP (1.5Mn), Spruce Street Capital LP (1.42Mn), RENAISSANCE TECHNOLOGIES LLC (1.35Mn), TWO SIGMA ADVISERS, LP (1.27Mn), Casdin Capital, LLC (1.23Mn), ACADIAN ASSET MANAGEMENT LLC (1.22Mn) per Business Quant data.